Raras
Buscar doenças, sintomas, genes...
Distrofia corneana, reticular, tipo I
ORPHA:98964CID-10 · H18.5CID-11 · 9A70.YOMIM 122200DOENÇA RARA

A Distrofia Corneana em Treliça Tipo 1 (DLCT1) é um tipo comum de doença da córnea que atinge a camada do meio (o estroma), caracterizada por um padrão em rede de manchas finas, ramificadas e que se entrelaçam, parecendo filamentos delicados, dentro da córnea. Isso causa uma piora progressiva da visão, mas não afeta outras partes do corpo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Distrofia Corneana em Treliça Tipo 1 (DLCT1) é um tipo comum de doença da córnea que atinge a camada do meio (o estroma), caracterizada por um padrão em rede de manchas finas, ramificadas e que se entrelaçam, parecendo filamentos delicados, dentro da córnea. Isso causa uma piora progressiva da visão, mas não afeta outras partes do corpo.

Publicações científicas
43 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H18.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

90%prev.
Opacificação central da córnea
Muito frequente (99-80%)
90%prev.
Opacidade corneana
Muito frequente (99-80%)
90%prev.
Cicatriz corneana
Muito frequente (99-80%)
90%prev.
Morfologia anormal da córnea
Muito frequente (99-80%)
90%prev.
Perda visual
Muito frequente (99-80%)
90%prev.
Distrofia corneana em treliça
Muito frequente (99-80%)
19sintomas
Muito frequente (6)
Frequente (7)
Ocasional (4)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 19 características clínicas mais associadas, ordenadas por frequência.

Opacificação central da córneaCentral opacification of the cornea
Muito frequente (99-80%)90%
Opacidade corneanaCorneal opacity
Muito frequente (99-80%)90%
Cicatriz corneanaCorneal scarring
Muito frequente (99-80%)90%
Morfologia anormal da córneaAbnormal cornea morphology
Muito frequente (99-80%)90%
Perda visualVisual loss
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico43PubMed
Últimos 10 anos6publicações
Pico20151 papers
Linha do tempo
2026Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

TGFBITransforming growth factor-beta-induced protein ig-h3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in cell adhesion (PubMed:8024701). May play a role in cell-collagen interactions (By similarity)

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Amyloid fiber formation
MECANISMO DE DOENÇA

Corneal dystrophy, epithelial basement membrane

A bilateral anterior corneal dystrophy characterized by grayish epithelial fingerprint lines, geographic map-like lines, and dots (or microcysts) on slit-lamp examination. Pathologic studies show abnormal, redundant basement membrane and intraepithelial lacunae filled with cellular debris.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
2960.5 TPM
Artéria tibial
227.8 TPM
Nervo tibial
206.8 TPM
Skin Sun Exposed Lower leg
200.2 TPM
Skin Not Sun Exposed Suprapubic
190.4 TPM
OUTRAS DOENÇAS (7)
Reis-Bucklers corneal dystrophycorneal dystrophy, lattice type 3AThiel-Behnke corneal dystrophygranular corneal dystrophy type I
HGNC:11771UniProt:Q15582

Variantes genéticas (ClinVar)

39 variantes patogênicas registradas no ClinVar.

🧬 TGFBI: NM_000358.3(TGFBI):c.1126+232G>T ()
🧬 TGFBI: NM_000358.3(TGFBI):c.1856T>A (p.Met619Lys) ()
🧬 TGFBI: NM_000358.3(TGFBI):c.911G>A (p.Arg304Lys) ()
🧬 TGFBI: NM_000358.3(TGFBI):c.1877A>C (p.His626Pro) ()
🧬 TGFBI: NM_000358.3(TGFBI):c.1517_1518insCAAGGG (p.Met506delinsIleLysGly) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 8 variantes classificadas pelo ClinVar.

6
2
Patogênica (75.0%)
VUS (25.0%)
VARIANTES MAIS SIGNIFICATIVAS
TGFBI: NM_000358.3(TGFBI):c.895G>A (p.Asp299Asn) [Conflicting classifications of pathogenicity]
TGFBI: NM_000358.3(TGFBI):c.1998G>C (p.Arg666Ser) [Conflicting classifications of pathogenicity]
TGFBI: NM_000358.2(TGFBI):c.[1637C>A;1652C>A] [Pathogenic]
TGFBI: NM_000358.3(TGFBI):c.1501C>A (p.Pro501Thr) [Pathogenic/Likely pathogenic]
TGFBI: NM_000358.3(TGFBI):c.370C>T (p.Arg124Cys) [Pathogenic]

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Distrofia corneana, reticular, tipo I

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
6 papers (10 anos)
#1

Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports.

Case reports in pathology2026

Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic, premalignant disease with a progression rate of 0.5%-1% per year to multiple myeloma. It can rarely present with significant ocular symptoms in the context of crystalline keratopathy, necessitating medical and surgical interventions. Lattice corneal dystrophy Type I (LCD-1), a rare inherited disorder caused by mutations of TGFBI, manifests with amyloid deposition within the corneal stroma and causes visual impairment. Here, we pictorially highlight protein deposition using immunofluorescence in two representative cases, both having undergone penetrating keratoplasty for blurry vision. Medical records were reviewed. Hematoxylin and eosin, special staining, immunohistochemistry, and immunofluorescent techniques were performed. A literature review was performed. Case 1: Eosinophilic accumulations of the cornea were highlighted with PAS-D and IgG-kappa by immunohistochemistry, whereas immunofluorescence (IF) technique demonstrated IgG-kappa (2+) staining in the stroma with rare globules in the epithelium. Case 2: Amorphous, eosinophilic deposits within the corneal stroma were congophilic with apple-green birefringence on polarized light. Thioflavin T highlighted the amyloid through immunofluorescence. Mass spectrometry detected a peptide profile consistent with ATGFBI-type amyloid deposition. Immunofluorescence can be helpful in the workup of corneal protein deposition, such as MGUS-related crystalline keratopathy and LCD-1.

#2

Descemet's Membrane Detachment During Cataract Surgery in Lattice Corneal Dystrophy Type I: Histopathological Analysis of Posterior Corneal Involvement.

Cureus2025 Mar

Lattice corneal dystrophy Type I (LCD1) is characterized by amyloid deposition in the corneal stroma, however its impact on Descemet's membrane adhesion remains poorly understood. This study reports a rare case of Descemet's membrane detachment (DMD) during cataract surgery in a patient with LCD1 and investigates the potential role of posterior corneal amyloid deposits in this complication. A 68-year-old male presented with LCD1 was admitted for cataract surgery for the left eye. DMD appeared during the irrigation and aspiration (I/A) phase after intraocular lens (IOL) implantation. After intraoperative partial removal of DM, persistent Descemet's membrane folds and corneal stromal edema developed the day after surgery. These complications did not improve over time, necessitating penetrating keratoplasty eight months later. Following the keratoplasty, the patient's vision improved to 0.5 LogMAR with an uneventful postoperative course. Pathological examination of the excised corneal tissue demonstrated the presence of Congo red stain-positive amyloid deposits in the posterior segment of the cornea, localized between the layers of Descemet's membrane and the corneal stroma. While it is established that amyloid deposition in the anterior segment of the cornea induces alterations in epithelial adhesion, leading to corneal erosions, the effects of deposits on DM adhesion in the posterior segment are yet to be fully understood. Our case's pathological findings suggested that these deposits may contribute to DMD. Therefore, careful monitoring of DM is crucial during cataract surgical interventions in patients diagnosed with LCD1.

#3

An Arg124Cys mutation in transforming growth factor β-induced gene associated with lattice corneal dystrophy type I in a Chinese pedigree.

Indian journal of ophthalmology2022 Jan

To identify a clinical and genetic form of a large Chinese family with an autosomal-dominant lattice corneal dystrophy type I (LCD I). The patients' eyes were examined on the basis of slit-lamp microscopy, and other clinical records were also collected. Genomic DNA was extracted from peripheral leukocytes of the affected patients and their unaffected family members. Each previous reported mutation of the transforming growth factor β-induced gene (TGFBI) gene was amplified by touch-down polymerase chain reaction and directly sequenced to verify the disease-causing mutation. Typical clinical features of LCD I were found by slit-lamp photography in these affected Chinese pedigrees. A heterozygous single base-pair transition from C to T (c.418 C > T), leading to amino acid substitution Arg124Cys (R124C) in the encoded TGFBI protein, was detected in all of the eighteen affected patients. The same mutation was not found in unaffected family members. The R124C mutation hot spot, which was relatively rare in China, was responsible for LCD I in the large family. Molecular genetic analysis of TGFBI gene can offer an accurate diagnosis of patients with lattice corneal dystrophies in the clinical treatment.

#4

Analysis of TGFBI Gene Mutations in Three Chinese Families with Corneal Dystrophy.

Journal of ophthalmology2019

To identify the types of TGFBI (transforming growth factor, beta-induced) gene mutations in three Chinese families with Reis-Bücklers corneal dystrophy (RBCD), lattice corneal dystrophy type I (LCDI), or Avellino corneal dystrophy (ACD) and to investigate the relationship between the phenotypes and genotypes of corneal dystrophy. Peripheral blood was collected from 24 patients and 76 phenotypically normal members in three Chinese families as well as from 100 healthy controls. Genomic DNA was extracted. All 17 exons of the TGFBI gene, and the exon-intron junctions were examined by polymerase chain reaction (PCR) and direct DNA sequencing to identify and analyse gene mutations. In addition, all members of the three families were subjected to detailed clinical examinations. The heterozygous c.371G > T (p.R124L) mutation was detected in exon 4 of the TGFBI gene in nine patients from the family with RBCD. In contrast, this mutation was not found in the phenotypically normal members of the family. The heterozygous c.370C > T (p.R124C) mutation was found in exon 4 of the TGFBI gene in 11 patients from the family with LCDI. This mutation was not found in the phenotypically normal members of the family. The heterozygous c.371G > A (p.R124H) mutation was detected in exon 4 of the TGFBI gene in four patients from the family with ACD. Again, this mutation was not found in the phenotypically normal members of the family. The TGFBI gene mutations cosegregated with the disease phenotypes in the three families and exhibited an autosomal dominant mode of inheritance. No TGFBI gene mutations were detected in the 100 healthy controls. There is a high degree of correlation between the phenotypes and genotypes of TGFBI-linked corneal dystrophies. R124 represents a mutational hotspot in the TGFBI gene. Gene mutation analysis provides a reliable basis for the definitive diagnosis of corneal dystrophy.

#5

Transforming growth factor β induced mutation-associated phenotype in a Chinese family exhibiting lattice corneal dystrophy.

Biomedical reports2017 Oct

Lattice corneal dystrophy type I (LCDI) is associated with a large number of missense mutations in the transforming growth factor β induced (TGFBI) gene. The aim of the present study was to analyze TGFBI mutation in a Chinese family with LCDI, and to describe the clinical features and phenotype-genotype correlation within this family. Three generations of this family with LCDI were enrolled in the current study. Complete ophthalmic examinations were performed on all family members and mutation screenings of the coding regions of TGFBI were analyzed using a direct sequencing method. All family members underwent slit-lamp examination, and two patients and one of normal members in the family were evaluated by laser scanning in vivo confocal microscopy. A single heterozygous c.370C>T (p.R124C) mutation was identified in exon 4 of the TGFBI gene in five affected individuals, but not in the other family members and 400 normal control subjects. The affected members exhibited similar clinical features of LCDI, except that patient III:5 presented with mild symptoms. Confocal microscopy in vivo examination demonstrated that the proband (II:2) and his affected niece (III:4) had disruptions in multiple corneal layers, including the basal epithelial cells, stroma cells and Bowman's membrane. Thus, the R124C mutation in the TGFBI gene was identified in a Chinese family with LCDI. These results characterized the clinical features and revealed a genotype-associated phenotype in this family, which may contribute to understanding the pathogenesis of LCDI.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Distrofia corneana, reticular, tipo I.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Distrofia corneana, reticular, tipo I

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports.
    Case reports in pathology· 2026· PMID 41726249mais citado
  2. Descemet's Membrane Detachment During Cataract Surgery in Lattice Corneal Dystrophy Type I: Histopathological Analysis of Posterior Corneal Involvement.
    Cureus· 2025· PMID 40296953mais citado
  3. An Arg124Cys mutation in transforming growth factor &#x3b2;-induced gene associated with lattice corneal dystrophy type I in a Chinese pedigree.
    Indian journal of ophthalmology· 2022· PMID 34937214mais citado
  4. Analysis of TGFBI Gene Mutations in Three Chinese Families with Corneal Dystrophy.
    Journal of ophthalmology· 2019· PMID 30805211mais citado
  5. Transforming growth factor &#x3b2; induced mutation-associated phenotype in a Chinese family exhibiting lattice corneal dystrophy.
    Biomedical reports· 2017· PMID 29085627mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98964(Orphanet)
  2. OMIM OMIM:122200(OMIM)
  3. MONDO:0007380(MONDO)
  4. GARD:9678(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Distrofia corneana, reticular, tipo I
Compêndio · Raras BR

Distrofia corneana, reticular, tipo I

ORPHA:98964 · MONDO:0007380
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
H18.5 · Distrofias hereditárias da córnea
CID-11
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1690006
EuropePMC
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades